rs4653695
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001136018.4(EPHX1):c.*35A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,352,544 control chromosomes in the GnomAD database, including 9,841 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 934 hom., cov: 0)
Exomes 𝑓: 0.11 ( 8907 hom. )
Consequence
EPHX1
NM_001136018.4 3_prime_UTR
NM_001136018.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.439
Genes affected
EPHX1 (HGNC:3401): (epoxide hydrolase 1) Epoxide hydrolase is a critical biotransformation enzyme that converts epoxides from the degradation of aromatic compounds to trans-dihydrodiols which can be conjugated and excreted from the body. Epoxide hydrolase functions in both the activation and detoxification of epoxides. Mutations in this gene cause preeclampsia, epoxide hydrolase deficiency or increased epoxide hydrolase activity. Alternatively spliced transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2008]
TMEM63A (HGNC:29118): (transmembrane protein 63A) Enables mechanosensitive ion channel activity. Predicted to be involved in cation transmembrane transport. Located in centriolar satellite and lysosomal membrane. Implicated in hypomyelinating leukodystrophy. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-225845382-A-C is Benign according to our data. Variant chr1-225845382-A-C is described in ClinVar as [Benign]. Clinvar id is 1248948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.275 AC: 14003AN: 50984Hom.: 932 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
14003
AN:
50984
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.119 AC: 17748AN: 148610 AF XY: 0.109 show subpopulations
GnomAD2 exomes
AF:
AC:
17748
AN:
148610
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.113 AC: 147549AN: 1301506Hom.: 8907 Cov.: 30 AF XY: 0.111 AC XY: 71045AN XY: 641998 show subpopulations
GnomAD4 exome
AF:
AC:
147549
AN:
1301506
Hom.:
Cov.:
30
AF XY:
AC XY:
71045
AN XY:
641998
Gnomad4 AFR exome
AF:
AC:
732
AN:
29308
Gnomad4 AMR exome
AF:
AC:
9039
AN:
34302
Gnomad4 ASJ exome
AF:
AC:
1438
AN:
21802
Gnomad4 EAS exome
AF:
AC:
3030
AN:
29644
Gnomad4 SAS exome
AF:
AC:
3853
AN:
78758
Gnomad4 FIN exome
AF:
AC:
6637
AN:
33086
Gnomad4 NFE exome
AF:
AC:
117050
AN:
1018912
Gnomad4 Remaining exome
AF:
AC:
5501
AN:
52100
Heterozygous variant carriers
0
6887
13775
20662
27550
34437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
4352
8704
13056
17408
21760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.275 AC: 14016AN: 51038Hom.: 934 Cov.: 0 AF XY: 0.275 AC XY: 7109AN XY: 25878 show subpopulations
GnomAD4 genome
AF:
AC:
14016
AN:
51038
Hom.:
Cov.:
0
AF XY:
AC XY:
7109
AN XY:
25878
Gnomad4 AFR
AF:
AC:
0.115643
AN:
0.115643
Gnomad4 AMR
AF:
AC:
0.399319
AN:
0.399319
Gnomad4 ASJ
AF:
AC:
0.184476
AN:
0.184476
Gnomad4 EAS
AF:
AC:
0.256336
AN:
0.256336
Gnomad4 SAS
AF:
AC:
0.169003
AN:
0.169003
Gnomad4 FIN
AF:
AC:
0.415305
AN:
0.415305
Gnomad4 NFE
AF:
AC:
0.281479
AN:
0.281479
Gnomad4 OTH
AF:
AC:
0.262363
AN:
0.262363
Heterozygous variant carriers
0
565
1130
1696
2261
2826
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at